Changeflow GovPing Pharma & Drug Safety US Patent Application for Heart Boosting Formul...
Routine Notice Added Draft

US Patent Application for Heart Boosting Formulation

Favicon for changeflow.com ChangeBridge: Patent Apps - Therapeutics (A61P)
Published September 16th, 2025
Detected March 27th, 2026
Email

Summary

The USPTO has published a new patent application (US20260083806A1) for a heart boosting formulation. The application details a specific composition including L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon, and beetroot, along with related manufacturing methods. The filing date was September 16, 2025.

What changed

This document is a publication of a United States patent application, specifically application number US20260083806A1, filed on September 16, 2025. The application describes a 'heart boosting formulation' comprising a specific list of ingredients including L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon, and beetroot, as well as related methods of manufacture.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property protection for a novel therapeutic formulation. Companies involved in the development or manufacturing of cardiovascular supplements or pharmaceuticals should be aware of this filing as it may impact future market exclusivity or licensing opportunities.

Source document (simplified)

← USPTO Patent Applications

Heart boosting formulation and related methods of manufacture

Application US20260083806A1 Kind: A1 Mar 26, 2026

Inventors

Kedar Prasad

Abstract

A heart boosting formulation comprises: L-carnitine, alpha-linolenic acid, citrulline, vitamin D3, lycopene, holy basil, cinnamon and beetroot.

CPC Classifications

A61K 36/54 A61K 31/01 A61K 31/198 A61K 31/202 A61K 31/205 A61K 31/593 A61K 36/21 A61K 36/53 A61P 9/00

Filing Date

2025-09-16

Application No.

18831814

View original document →

Named provisions

Heart boosting formulation and related methods of manufacture

Classification

Agency
USPTO
Published
September 16th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083806A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Formulation Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Drug Development Dietary Supplements

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.